Shots:
- The US FDA has granted 510(k) clearance to ABANZA’s QuadLock Fixation System, a knotless, bidirectional, tension-adjustable device for anterior cruciate ligament (ACL) reconstruction
- In biomechanical testing under high-demand cyclic loading, QuadLock demonstrated <0.5 mm cyclic displacement representing a >500% reduction in cyclic displacement and >1,000 N pullout strength vs conventional fixation methods
- QuadLock is designed to support multiple graft configurations, including quadriceps tendon, quadrupled semitendinosus/gracilis, and bone-patellar tendon-bone (BTB), expanding fixation options across varying patient bone quality
Ref: PR Newswire | Image: ABANZA | Press Release
Related News: ABANZA Reports the US FDA 510(k) Clearance of WasherCap Mini for Orthopedic Surgeries
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
